STOCK TITAN

NEXGEL to Report First Quarter 2024 Financial Results on May 13th

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

NEXGEL, Inc. will report its first quarter 2024 financial results on May 13th, followed by a conference call at 4:30 P.M. ET. The company is a leading provider of medical and over-the-counter products, including hydrogels for healthcare and consumer applications.

Positive
  • None.
Negative
  • None.

Management will host a conference call at 4:30 P.M. ET on the same day

LANGHORNE, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced it will report its financial results for the first quarter 2024, after the market closes on May 13, 2024. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET on the same day.

First Quarter 2024 Financial Results Conference Call
Date: May 13, 2024
Time: 4:30 P.M. ET
Live Call: + 1-800-343-5419 (U.S. Toll Free) or + 1-203-518-9731 (International)
Webcast: Events and Presentations

For interested individuals unable to join the conference call, a replay will be available through May 27, 2024 by dialing + 1-844-512-2921 (U.S. Toll Free) or + 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11155952. An archived version of the webcast will also be available for 90 days.

About NEXGEL, INC.

NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
valter@kcsa.com


FAQ

When will NEXGEL report its first quarter 2024 financial results?

NEXGEL will report its first quarter 2024 financial results on May 13th.

What time will the conference call regarding the financial results take place?

The conference call will be held at 4:30 P.M. ET on the same day.

What products does NEXGEL specialize in?

NEXGEL is a leading provider of medical and over-the-counter products, including hydrogels for healthcare and consumer applications.

NexGel, Inc

NASDAQ:NXGL

NXGL Rankings

NXGL Latest News

NXGL Stock Data

16.32M
6.77M
21.73%
2.35%
0.32%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
LANGHORNE